[Can benign and malignant thyroid nodules be differentiated with thallium 201?]

Area of Science:

• Nuclear medicine
• Endocrinology
• Oncology

Background:

• Thyroid nodules are common, with a subset harboring malignancy.
• Accurate diagnosis of thyroid nodules is crucial for appropriate management.
• Current diagnostic methods may have limitations in differentiating benign from malignant nodules.

Purpose of the Study:

• To evaluate the diagnostic performance of Thallium 201 (Tl-201) radionuclide scanning for thyroid nodules.
• To assess the utility of Tl-201 scanning in identifying nodules that require surgical intervention.
• To compare the effectiveness of Tl-201 scanning with other diagnostic modalities.

Main Methods:

• Systematic review and analysis of 16 international studies.
• Inclusion of over 1601 thyroid examinations.
• Focus on Tl-201 uptake in cold nodules (detected by Tc 99 m or I 123) relative to surrounding thyroid tissue.

Main Results:

• Tl-201 scanning demonstrated a sensitivity of 91.3% for diagnosing thyroid nodules requiring surgery.
• A negative Tl-201 scan effectively ruled out cancer risk with a negative predictive value exceeding 97%.
• The test is applicable to isolated, multiple, and multinodular goiters, addressing a broad range of thyroid conditions.

Conclusions:

• Thallium 201 radionuclide scanning is a valuable tool for evaluating thyroid nodules.
• Its high sensitivity and negative predictive value support its use in surgical decision-making for thyroid nodules.
• Tl-201 scanning offers advantages over cytology alone, particularly in complex cases like multinodular goiters.